Marc Rubin, Director at GALECTIN THERAPEUTICS INC (GALT.OB), bought 20,000 shares at $0.96 ($19K) on 2011-10-18, disclosed to the SEC on 2011-10-20.
Open-market purchase of $19k GALT.OB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| TTNP | BUY | 2018-09-25 | $100K | — | Filing → |
| GALT | SELL | 2018-09-06 | $78K | — | Filing → |
| GALT | SELL | 2018-09-04 | $353K | — | Filing → |